Russell Frank Company’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$2.4M Buy
154,613
+40,781
+36% +$585K ﹤0.01% 1760
2015
Q4
$1.99M Buy
113,832
+22,656
+25% +$328K ﹤0.01% 1835
2015
Q3
$1.11M Buy
91,176
+62,000
+213% +$795K ﹤0.01% 2150
2015
Q2
$352K Sell
29,176
-36,208
-55% -$356K ﹤0.01% 2682
2015
Q1
$548K Buy
65,384
+8,184
+14% +$64.2K ﹤0.01% 2381
2014
Q4
$436K Buy
+57,200
New +$409K ﹤0.01% 2431

Other funds holding LMAT

Russell Frank Company's LMAT Position: Q1 2016 in Review

Russell Frank Company increased its LeMaitre Vascular (LMAT) stake by 36% in Q1 2016, buying an estimated $585K and bringing the position to 154,613 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

Russell Frank Company first reported a position in LMAT in Q4 2014 and has held it in 6 quarters since. 95 funds tracked by Wall St. Rank hold LMAT as of Q1 2016.

  • Russell Frank Company held 154,613 shares of LeMaitre Vascular worth $2.4M as of Q1 2016.
  • Russell Frank Company bought 40,781 LeMaitre Vascular shares in Q1 2016, an estimated $585K.
  • LeMaitre Vascular made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1760 holding.
  • Russell Frank Company first reported a position in LeMaitre Vascular in Q4 2014 and has held it in 6 quarters since.
  • 95 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.